Confindustria Prize, Farmalabor is one of the 20 most innovative companies in Italy

Why do we choose Indena products

In order to make our supplements even more effective, we invested on the quality of Indena certified extracts:- obtained from raw materials grown by validated and controlled processes in accordance with the "Good Agricultural and Collection Practices";- made through well-known and accredited methods for establishing their essay in active components.For instance, we used Meriva® Indena for Naturtarticol formulation. It is a patented form for releasing curcumin, based on Indena's phytosome technology: this type of formulation is an innovative releasing system, useful for improving the pharmacokinetic profile of poorly bioavailable phytoconstituents.The active components with high polarity could, in fact, do not cross the lipid barrier of the gastrointestinal wall, and thus not be absorbed.The innovative technology of phytosome, in addition to ensuring the stability of the extract, improves their bioavailability and efficacy, thanks to its ability to cross high-lipid biological membranes.Another example is Naturflux. Its effectiveness is related to Mirtoselect® Indena which is a blueberry extract, standardized using a new HPLC method (developed and validated by Indena especially for the characterization of this extract).This method uses the cyanidin-3-glucoside as external standard and the content of each anthocyanin is determined by weight, through an appropriate correction factor.

Farmalabor, Italian excellence in Serbia

An important cooperation agreement between Farmalabor and the pharmaceutical company Esensa was signed on 11 March 2014 in Belgrade, at the Chamber of Commerce and Industry of Serbia (PKS).Esensa produces dietary supplements and medical devices for the Serbian market. The aim of this agreement is the exclusive distribution of Farmalabor products (raw materials, technical furniture for galenic laboratory and packaging items) in fast-growing markets such as Serbia, Montenegro, Macedonia and the Serbian Republic of Bosnia and Herzegovina.Farmalabor proved to be not only a leading provider of pharmacies, galenic laboratories and hospitals in Italy, but also a reliable business partner . Esensa representative stated that this agreement is only the beginning of a collaboration set to become even stronger, with mutual benefits (Saradnja kompanija Esensa i Farmalabor, "Poslovno Jutro", 11.03.2014).Dr. Sergio Fontana, CEO of Farmalabor, expresses his opinion about the agreement: “In times of economic crisis, the only way to survive is investing , expanding your business horizons . The agreement with Esensa is a response to it. I'm sure that Serbian marketers will be impressed by the quality of our products and services”.

“Vis Maris”: the grape extract for the health of fishes

The press conference for “Vis Maris” project, in partnership with the University of Bari "Aldo Moro", was held on Tuesday, April 15th 2014 at the Research Center "Sergio Fontana, 1900-1982". The project concerns the evaluation of the health qualities of the small-berry Troia grape, for the production of antioxidant-rich nutritional supplements for disease prevention. These are the main outcomes:- healthier fishes;- lower rate use of antibiotics and vaccines;- higher quality and comfort for consumers.In particular, the aim of the research was to evaluate the effect of polyphenols on the immune defence system of sea basses. The trial involved about 44,000 bass fingerlings fed with three different diets (standard fish food, fish food with grape extract added - 100 mg/kg, fish food with grape extract added - 200 mg/kg). The experiments showed immunomodulatory activity of polyphenols in grapes on the side of anti-inflammatory. Alongside the scientific issues, the press conference has provided concrete examples and insights in the research and innovation field. The speakers put emphasis on what innovation really is: a way to turn knowledge into practice and build connections between companies and institutions.

Farmalabor received an award for quality

Farmalabor won the award Farmaffari 2014 “Total Quality: Zero Deviations” during the 54th Symposium AFI (Pharmaceutical Industry Association), the most important event in the Italian Pharmaceutical sector that took place in Rimini- Italy- from 11th to 13th of June 2014.The award was established to promote the pharmaceutical industries engaged in the research of total quality; the involved companies are those who, after AIFA (Italian Medicines Agency) inspection, received in their final report, no major deviations and less than five “other” deviations according to the Good Manufacturing Practice.The celebratory plaque was given to Dott. Sergio Fontana, Chief Executive Officer of the Apulian pharmaceutical company, who shares this award with all Farmalabor employees: “This award has 80 faces, the faces of those who work in our company, Farmalabor, in an efficient and conscious way, focusing their different compentences on common objectives. Their commitment reminds me that our strategy is winning: investing in quality of systems, procedures and productive process even during a difficult economic period. For us, even in time of crisis, quality is always the best investment.

Medical Cannabis, Farmalabor receives the authorization from the Ministry

The Apulian pharmaceutical company Farmalabor was authorized by the Ministry of Health – Central Office of narcotic drugs for the wholesale of medical preparations made with Cannabis.Farmalabor is the only company for the pharmaceutical distribution in the Central and Southern Italy to have obtained this authorization and one of the two Italian companies that can market Cannabis vegetable-derived substances.The usable varieties of Cannabis Flos are Bedrocan, Bedrobinol, Bediol and Bedica, useful for their dronabinol (THC) and cannabidiol content in treatments for different diseases such as ALS (amyotrophic lateral sclerosis).Product will be sell to private and hospital pharmacies for the extemporaneous preparations after medical prescription. In fact, in accordance with the Decree of Ministry of Health of 23rd January 2013, doctors can use in treatments not only THC but also vegetable compounds with THC, included extracts and tinctures made with Cannabis.The medical use of cannabinoids is authorized by the Italian Law.«This is an important aim for us – says the CEO of Farmalabor Sergio Fontana – that goes together with the authorization obtained by AIFA (Italian Medicines of Agency) for the production of API (Active Pharmaceutical Ingredients) in 2010.We will obviously work in full compliance with the legislation and in harmony with the indications of the Minister of Health Beatrice Lorenzin who many times underlined the importance of a highly professional modus operandi in working with cannabinoids for their pharmacological and political-cultural implications. We will manage these substances with the same quality and safety that always characterize Farmalabor and the whole Italian Pharmaceutical sector, offering to patients the possibility to have access to official medical cares without any problem».

Confindustria Prize, Farmalabor is one of the 20 most innovative companies in Italy

You may also be interested

Why do we choose Indena products

Farmalabor, Italian excellence in Serbia

“Vis Maris”: the grape extract for the health of fishes

Farmalabor received an award for quality

Medical Cannabis, Farmalabor receives the authorization from the Ministry

Cookie Preferences

Name

Provider

Description

Deadline

Type

Name

Provider

Description

Deadline

Type